Home / Letter From The Editor / Oct. 15, 2019

Oct. 15, 2019

Oct 15, 2019
 

Our former intern, Amber Satz, PharmD Candidate, LECOM School of Pharmacy, was reviewing some info on GLP-1 Analogs and came across a new entry into the class.

Efpeglenatide is a new weekly analog from Sanofi. It appears to be as effective as all other weekly’s out there, and it will be interesting to see what the delivery device looks like and how they will price it to compete in a crowded market. Check what Amber learned in her research by clicking here.

 

 

 

Dave Joffe

Editor-in-chief